Bienvenue dans la collection de l'équipe Neural plasticity and degeneration de l'INP
Cette collection accueille la production scientifique déposée par les chercheurs, enseignants-chercheurs et doctorants de l'équipe.
Elle permet notamment :
- d'assurer une large diffusion des résultats de la recherche produite par le laboratoire
- d'accroître la visibilité de la production scientifique des chercheurs du laboratoire, accessible librement et indexée par la plupart des moteurs de recherche
Derniers documents déposés
-
-
Pedro Belio-Mairal, Athina Kamitsou, Delphine Stephan, Nicolas Jullien, Diarra Thiane, et al.. Mutations in specific domains of MT5-MMP prevent the accumulation of toxic APP metabolites and serve as templates for peptide-based therapeutics in human in vitro models of Alzheimer's disease. 2024. ⟨hal-04642476⟩
-
-
Dominika Pilat, Jean-Michel Paumier, Laura García-González, Laurence Louis, Delphine Stephan, et al.. MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease. Journal of Neuroinflammation, In press, ⟨10.1186/s12974-022-02407-z⟩. ⟨hal-03570912⟩
-
Laura García‐gonzález, Jean‐michel Paumier, Laurence Louis, Dominika Pilat, Anne Bernard, et al.. MT5‐MMP controls APP and β‐CTF/C99 metabolism through proteolytic‐dependent and ‐independent mechanisms relevant for Alzheimer's disease. FASEB Journal, 2021, 35 (7), ⟨10.1096/fj.202100593r⟩. ⟨hal-03431629⟩
-
Nikita Arnst, Pedro Belio-Mairal, Laura García-González, Laurie Arnaud, Louise Greetham, et al.. Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes. Cells, 2021, 10 (7), pp.1705. ⟨10.3390/cells10071705⟩. ⟨hal-03423990⟩
-
-
-
-
Patrizia Giannoni, Florence Gaven, Dimitri de Bundel, Kévin Baranger, Evelyne Marchetti-Gauthier, et al.. Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer’s disease. Frontiers in Aging Neuroscience, 2013, 5, pp.96. ⟨10.3389/fnagi.2013.00096⟩. ⟨hal-01703910⟩
-
-
Kévin Baranger, Manuel van Gijsel-Bonnello, Delphine Stephan, Wassila Carpentier, Santiago Rivera, et al.. Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer’s Disease Pathogenesis in a Transgenic Mouse Model. Neurotherapeutics, 2019, ⟨10.1007/s13311-019-00754-z⟩. ⟨hal-02339537⟩
-
Kévin Baranger, Amandine E Bonnet, Stéphane D Girard, Michel Paumier, Laura García-González, et al.. MT5-MMP Promotes Alzheimer's Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking in vitro. Frontiers in Molecular Neuroscience, 2017, 9, pp.163. ⟨10.3389/fnmol.2016.00163⟩. ⟨hal-01479008⟩
-
Nadine Crouzin, Kevin Baranger, Mélanie Cavalier, Yannick Marchalant, Catherine Cohen-Solal, et al.. Area-specific alterations of synaptic plasticity in the 5XFAD mouse model of Alzheimer's disease: dissociation between somatosensory cortex and hippocampus. PLoS ONE, 2013, 8 (9), pp.e74667. ⟨10.1371/journal.pone.0074667⟩. ⟨hal-00868441⟩
-
Manuel Van Gijsel-Bonnello, Kévin Baranger, Philippe Benech, Santiago Rivera, Michel Khrestchatisky, et al.. Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine. PLoS ONE, 2017, 12 (4), pp.e0175369. ⟨10.1371/journal.pone.0175369⟩. ⟨hal-01718180⟩
Se créer un compte ? Retrouver son identifiant ou son mot de passe ? Déposer ?... Connectez-vous !
|
Référents publications :
Montse Goutierrez Tél. 04 91 69 89 04 maria-montserrat.goutierrez@univ-amu.fr Denis Becquet Tél. 04 91 69 88 92 denis.becquet@univ-amu.fr |